MORE ARTICLES
Josh Smith on Immigrants’ Role in Economic RecoveryAugust 11, 2022 - 9:44 am
Economic Opportunity DirectorAugust 10, 2022 - 2:44 pm
William & Mary’s Dr. Charles Hobson on Chief Justice John Marshall, SCOTUS, & Judicial ReviewAugust 10, 2022 - 11:16 am
Drug Price Control: Bad Medicine for Healthcare and RegionAugust 9, 2022 - 10:36 am
Massachusetts Needs a Comprehensive Performance Management FrameworkAugust 9, 2022 - 8:17 am
The Realities Behind US Healthcare SpendingAugust 8, 2022 - 3:26 pm
Cures for Patients, Not Health Plan Profits, Make Drugs ValuableAugust 8, 2022 - 10:31 am
Khamzat Asabaev Wants to Put a Smile on Your FaceAugust 4, 2022 - 11:32 am
School-Age Population Remains Steady, but Boston Struggles With Declining EnrollmentAugust 4, 2022 - 10:40 am
Is a Universal Basic Income the future? You decide.August 3, 2022 - 1:52 pm
Stay Connected!
Receive the latest updates in your inbox.
William & Mary’s Dr. Charles Hobson on Chief Justice John Marshall, SCOTUS, & Judicial Review
/in Featured, Podcast, US History /by Editorial StaffThis week on “The Learning Curve,” co-hosts Cara Candal and Gerard Robinson talk with Dr. Charles Hobson, a retired resident scholar at the William & Mary Law School, 26-year editor of The Papers of John Marshall, and author of The Great Chief Justice: John Marshall and the Rule of Law. Dr. Hobson shares what students should know about the longest-serving, most important chief justice in the history of the Supreme Court, and his influence on our understanding of the U.S. Constitution.
Drug Price Control: Bad Medicine for Healthcare and Region
/in Featured, Healthcare, Podcast Hubwonk /by Editorial StaffHubwonk host Joe Selvaggi talks with Dr. Bill Smith, Director of Pioneer Institute’s Life Sciences Initiative, about the impact of the Inflation Reduction Act on long-term health costs. They discuss the bill’s unintended consequences, potential effect on the region’s vibrant pharmaceutical research and development sector, and what citizens can do about it.
Massachusetts Needs a Comprehensive Performance Management Framework
/0 Comments/in Better Government, Blog, Blog: Better Government, Blog: Transparency, Blogroll, News, Transparency /by Joseph StaruskiMassachusetts tried making a performance structure, but in 2014 it was discontinued. Today, the state lacks a comprehensive structure to track progress.
The Realities Behind US Healthcare Spending
/in Blog: Healthcare, Featured, Healthcare, Life Sciences /by Gauri BinoyHealthcare policy is an all-encompassing term. It plays a role in every individual’s life; how it is curated, developed, and maintained has a significant long-term impact on the quality of life of any given community. It is critical that policymakers consistently adapt and amend healthcare policies in the ever-changing global pricing and affordability environment while providing funding support for optimal quality of care.
Cures for Patients, Not Health Plan Profits, Make Drugs Valuable
/in Featured, Life Sciences /by William SmithTo the astonishment of many observers, the Institute for Clinical and Economic Review (ICER) recently concluded that a $2.1 million gene therapy for a life-threatening blood disorder called beta thalassemia, is priced cost-effectively. The surprise was especially pleasant, given that ICER’s methodology had, in the past, displayed bias against rare disease treatments and undervalued the lives of people living with disabilities.